Biodesix (BDSX) Share-based Compensation (2019 - 2026)

Biodesix (BDSX) has reported Share-based Compensation for 8 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $1.1 million, up 14.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (down 13.84% YoY), and the FY2025 annual result was $4.1 million, down 37.65% from the prior year.
• Share-based Compensation was $1.1 million for Q1 2026 at Biodesix, up from $1.1 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $2.6 million in Q1 2024 and troughed at $954000.0 in Q3 2023.
• Average Share-based Compensation over 5 years is $1.4 million, with a median of $1.2 million recorded in 2022.
• Year-over-year, Share-based Compensation surged 153.8% in 2022 and slumped 63.18% in 2025.
• Over 5 years, Share-based Compensation stood at $2.1 million in 2022, then slumped by 47.95% to $1.1 million in 2023, then climbed by 17.02% to $1.3 million in 2024, then dropped by 15.02% to $1.1 million in 2025, then climbed by 3.72% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.